Gamers Solve RNA Structures

An online competition gives citizen scientists a chance to design RNA molecules to generate a target structure.

Written byAbby Olena, PhD
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

CARNEGIE MELLON UNIVERSITY AND STANFORD UNIVERSITYPredicting RNA folding can be complex, even with the best in silico models. To help address this challenge, researchers created a game called EteRNA, which after being played by more than 37,000 citizen scientists online, helped generate a new algorithm that predicts RNA folding more accurately than previous algorithms. Details of the game and its findings were published yesterday (January 27) in PNAS.

“It's pretty amazing stuff,” Erik Winfree of the California Institute of Technology, who did not participate in the research, told ScienceNOW.

Every week, EteRNA participants designed sequences based on a target structure in the browser-based gaming interface. The top eight possibilities were chosen by the players’ vote and then synthesized and analyzed in the lab. Based on the reported folding outcomes of the chosen sequences, users developed a collection of design rules. To test the rules, some of which were unique and had not been previously used to design structured RNAs, the research team distilled the rules into an algorithm called EteRNABot. The EteRNA community and EteRNABot consistently designed RNAs that folded into the target structures in vitro more often than other algorithms.

“Many areas ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • abby olena

    As a freelancer for The Scientist, Abby reports on new developments in life science for the website. She has a PhD from Vanderbilt University and got her start in science journalism as the Chicago Tribune’s AAAS Mass Media Fellow in 2013. Following a stint as an intern for The Scientist, Abby was a postdoc in science communication at Duke University, where she developed and taught courses to help scientists share their research. In addition to her work as a science journalist, she leads science writing and communication workshops and co-produces a conversational podcast. She is based in Alabama.  

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies